Growth rate-corrected (GR) dose-response metrics across a panel of 71 breast cancer cell lines treated with a library of small molecule and antibody perturbagens. Dataset 1 of 4: Relative cell counts and normalized growth rate inhibition values across technical replicates. - Dataset - HMS LINCS Database

Growth rate-corrected (GR) dose-response metrics across a panel of 71 breast cancer cell lines treated with a library of small molecule and antibody perturbagens. Dataset 1 of 4: Relative cell counts and normalized growth rate inhibition values across technical replicates. - Dataset (ID:20268)

Download: Excel (XLSX), Comma-separated (CSV)

<<<<

Select the entities to show:

Small molecules	Cells	Antibodies

|<
<<
Previous
Page 1001 of 3330
Next
>>
>
25001 to 25025 of 83232 records
per page:

Cell	Clinical Subtype	Transcriptional Subtype	Small Molecule	Perturbagen Target	Perturbagen Class	Perturbagen Concentration	Perturbagen Conc Unit	Biological Replicate ID	Relative Cell Count	Normalized Growth Rate Inhibition Value	Nominal Division Rate
HCC1419	HER2amp	Luminal	Everolimus	MTOR	MTOR	13.3	uM	12001.164	0.6367	-0.2362	0.4690
HCC1419	HER2amp	Luminal	Everolimus	MTOR	MTOR	66.7	uM	12001.164	0.4377	-0.6565	0.4690
HCC1428	HR+	Luminal	Everolimus	MTOR	MTOR	0.000171	uM	11936.164	0.9602	0.9090	0.8717
HCC1428	HR+	Luminal	Everolimus	MTOR	MTOR	0.000853	uM	11936.164	0.9456	0.8757	0.8717
HCC1428	HR+	Luminal	Everolimus	MTOR	MTOR	0.00427	uM	11936.164	0.9277	0.8351	0.8717
HCC1428	HR+	Luminal	Everolimus	MTOR	MTOR	0.0213	uM	11936.164	0.9040	0.7812	0.8717
HCC1428	HR+	Luminal	Everolimus	MTOR	MTOR	0.107	uM	11936.164	0.8242	0.6021	0.8717
HCC1428	HR+	Luminal	Everolimus	MTOR	MTOR	0.533	uM	11936.164	0.7623	0.4649	0.8717
HCC1428	HR+	Luminal	Everolimus	MTOR	MTOR	2.67	uM	11936.164	0.7509	0.4398	0.8717
HCC1428	HR+	Luminal	Everolimus	MTOR	MTOR	13.3	uM	11936.164	0.7187	0.3691	0.8717
HCC1428	HR+	Luminal	Everolimus	MTOR	MTOR	66.7	uM	11936.164	0.0356	-0.9565	0.8717
HCC1569	HER2amp	Basal A	Everolimus	MTOR	MTOR	0.000171	uM	10872.156	0.9368	0.9150	1.5028
HCC1569	HER2amp	Basal A	Everolimus	MTOR	MTOR	0.000853	uM	10872.156	0.9242	0.8978	1.5028
HCC1569	HER2amp	Basal A	Everolimus	MTOR	MTOR	0.00427	uM	10872.156	0.8152	0.7457	1.5028
HCC1569	HER2amp	Basal A	Everolimus	MTOR	MTOR	0.0213	uM	10872.156	0.7471	0.6474	1.5028
HCC1569	HER2amp	Basal A	Everolimus	MTOR	MTOR	0.107	uM	10872.156	0.6399	0.4859	1.5028
HCC1569	HER2amp	Basal A	Everolimus	MTOR	MTOR	0.533	uM	10872.156	0.6496	0.5010	1.5028
HCC1569	HER2amp	Basal A	Everolimus	MTOR	MTOR	2.67	uM	10872.156	0.6631	0.5215	1.5028
HCC1569	HER2amp	Basal A	Everolimus	MTOR	MTOR	13.3	uM	10872.156	0.6165	0.4495	1.5028
HCC1569	HER2amp	Basal A	Everolimus	MTOR	MTOR	66.7	uM	10872.156	0.0234	-0.8357	1.5028
HCC1569	HER2amp	Basal A	Everolimus	MTOR	MTOR	0.000171	uM	12523.164	0.9588	0.9002	0.8230
HCC1569	HER2amp	Basal A	Everolimus	MTOR	MTOR	0.000853	uM	12523.164	0.9224	0.8130	0.8230
HCC1569	HER2amp	Basal A	Everolimus	MTOR	MTOR	0.00427	uM	12523.164	0.8517	0.6455	0.8230
HCC1569	HER2amp	Basal A	Everolimus	MTOR	MTOR	0.0213	uM	12523.164	0.7639	0.4419	0.8230
HCC1569	HER2amp	Basal A	Everolimus	MTOR	MTOR	0.107	uM	12523.164	0.7117	0.3230	0.8230

|<
<<
Previous
Page 1001 of 3330
Next
>>
>
25001 to 25025 of 83232 records
per page:

HMS LINCS Project

Growth rate-corrected (GR) dose-response metrics across a panel of 71 breast cancer cell lines treated with a library of small molecule and antibody perturbagens. Dataset 1 of 4: Relative cell counts and normalized growth rate inhibition values across technical replicates. - Dataset (ID:20268)